+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Novavax Inc - logo

Novavax is a clinical-stage vaccine company that develops recombinant nanoparticle vaccines and adjuvants. The company produces its vaccines using its proprietary recombinant nanoparticle vaccine technology. Its product pipeline includes respiratory syncytial virus (RSV) vaccine candidates for elderly and maternal immunization, seasonal quadrivalent influenza and pandemic H7N9 vaccines, a vaccine candidate against Ebola Virus and others. Founded in 1987, it is headquartered in Gaithersburg, Maryland.

Diphtheria Global Market Report 2024 - Product Thumbnail Image

Diphtheria Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
From
Antivirals Global Market Report 2024 - Product Thumbnail Image

Antivirals Global Market Report 2024

  • Report
  • November 2023
  • 175 Pages
  • Global
From
Seasonal Influenza Vaccines - Product Thumbnail Image

Seasonal Influenza Vaccines

  • Report
  • October 2020
  • 51 Pages
  • Global
Coronavirus (COVID-19) Current Therapy Global Market Report 2023 - Product Thumbnail Image

Coronavirus (COVID-19) Current Therapy Global Market Report 2023

  • Report
  • February 2023
  • 250 Pages
  • Global
From
From
Influenza - Pipeline Insight, 2024 - Product Thumbnail Image

Influenza - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 280 Pages
  • Global
From
Respiratory Syncytial Virus (RSV): Forecast in Asia-Pacific Markets to 2028 - Product Thumbnail Image

Respiratory Syncytial Virus (RSV): Forecast in Asia-Pacific Markets to 2028

  • Report
  • November 2019
  • 153 Pages
  • Asia Pacific
From
From
Loading Indicator